• bioAffinity Technologies closed a private placement of pre-funded warrants covering 8,462,027 common shares.
• Combined effective offering price set at USD 0.47 per pre-funded warrant with two accompanying warrants.
• Gross proceeds expected at about USD 4 million before fees and expenses.
• Pre-funded warrants carry a USD 0.01 exercise price; accompanying warrants priced at USD 0.47, expire in five years.
• Warrants become exercisable following stockholder approval; WallachBeth Capital served as sole placement agent.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260814633801) on August 14, 2026, and is solely responsible for the information contained therein.